The Evolution of a National Public Health Initiative on Diabetes and Women's Health: A Model Process

2003 ◽  
Vol 12 (9) ◽  
pp. 839-845 ◽  
Author(s):  
Ana Alfaro-Correa Sc.D., M.A. ◽  
Gloria Beckles ◽  
Christopher Benjamin ◽  
Barbara Bowman ◽  
Yvonne Green ◽  
...  
Keyword(s):  
Public Health ◽  
Women’S Health ◽  
Women's Health ◽  
Health Initiative ◽  
Public Health Initiative ◽  
National Public Health

Women's Health Initiative: Why now? What is it? What's new?

1997 ◽  
Vol 52 (2) ◽  
pp. 101-116 ◽  
Author(s):  
Karen A. Matthews ◽  
Sally A. Shumaker ◽  
Deborah J. Bowen ◽  
Robert D. Langer ◽  
Julie R. Hunt ◽  
...  
Keyword(s):  
Women’S Health ◽  
Women's Health ◽  
Women's Health Initiative ◽  
Women’S Health Initiative ◽  
Health Initiative

Bisphosphonate zur Brustkrebsprävention?

2010 ◽  
Vol 01 (01) ◽  
pp. 13-14
Author(s):  
Katharina Arnheim
Keyword(s):  
Los Angeles ◽  
Women’S Health ◽  
Women's Health ◽  
Women's Health Initiative ◽  
Women’S Health Initiative ◽  
Health Initiative

Seit mehreren Jahren wird darüber diskutiert, ob und inwieweit Brustkrebspatientinnen in der adjuvanten Situation von einer zusätzlichen Bisphosphonatgabe profitieren. Für die adjuvante Gabe von Bisphosphonaten sprechen die Studien ABCSG 12 bei prämenopausalen und ZO-FAST bei postmenopausalen Patientinnen. Anhand der Daten von 10 000 Frauen der Women’s Health Initiative (WHI) prüfte die Arbeitsgruppe um Prof. Rowan Chlebowski, Los Angeles/USA, die Assoziation zwischen oralen Bisphosphonaten und der Brustkrebsinzidenz (1).

Sign in / Sign up

Export Citation Format

Share Document